Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Rt 2013 SR
The report details Gedeon Richter's sustainability performance for 2012-2013, highlighting its transition into a European multinational 'speciality pharma' company. Key achievements include the inauguration of a modern biotechnology plant in Debrecen and the filing of a registration application for cariprazine. The company emphasizes its commitment to R&D, investing approximately 12% of sales revenue, and details its environmental management systems (ISO 14001) and occupational health and safety (OHSAS 18001). It also introduces environmental data for its foreign manufacturing subsidiaries for the first time.
Company: Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Rt
Sector: Manufacturing
Country: Hungary
Year: 2013
Type: SR
Pages: 41
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Rt
The report details Gedeon Richter's sustainability performance for 2012-2013, highlighting its transition into a European multinational 'speciality pharma' company. Key achievements include the inauguration of a modern biotechnology plant in Debrecen and the filing of a registration application for cariprazine. The company emphasizes its commitment to R&D, investing approximately 12% of sales revenue, and details its environmental management systems (ISO 14001) and occupational health and safety (OHSAS 18001). It also introduces environmental data for its foreign manufacturing subsidiaries for the first time.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jan 1, 2012 - Dec 31, 2013
Fiscal Year
2013
Published
Jun 30, 2014
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees